Healthy volunteers test new drug in early safety trial
Knowledge-focused
Terminated
This early-stage study tested a new drug called iCP-NI in 24 healthy adults to check its safety and how the body processes it. Participants received either the drug or a placebo through an IV. The study was terminated early, and no treatment for any disease was involved.
Phase: PHASE1 • Sponsor: Cellivery Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 17, 2026 01:47 UTC